Frank D’Amelio Net Worth 2026: The Real Numbers Behind the Name

Who Is Frank D’Amelio?

The name Frank D’Amelio refers to two distinct individuals with overlapping career fields but divergent financial profiles. The first, Frank D’Amelio, is a corporate/entertainment figure known for his work in finance and real estate. The second, Frank A. Damelio, is a high-ranking executive and board member at major pharmaceutical companies like Pfizer and Humana. This confusion has led to conflicting net worth estimates across sources.

Corporate Executive vs. Board Member

Frank D’Amelio’s career began in the 1970s at Price Waterhouse (now PwC), where he rose to partner. By the late 1980s, he joined General Electric under Jack Welch, later becoming a CFO. His real estate holdings, including a $10 million+ home in Greenwich, Connecticut, and investments in technology and healthcare form his primary wealth sources.

Frank A. Damelio, meanwhile, is an Executive Vice President at Pfizer, overseeing corporate finance. His net worth is tied to stock holdings in Pfizer (PFE), Humana (HUM), and Zoetis (ZOET), as well as board roles at Zoetis and Humana. As of June 2026, he owns 555,941 shares of PFE stock.

Career Milestones

• 1970s: Joined Price Waterhouse as an accountant, specializing in audit and tax services.
• 1980s: Became CFO at General Electric under Jack Welch, instrumental in restructuring GE’s financial operations.
• 2000s: Transitioned to Pfizer, where he played a key role in managing financial strategies during the company’s expansion into global markets.
• 2020s: Served as a board member at Humana and former Chairman of Zoetis, leveraging his expertise in healthcare finance.

The Net Worth Controversy: Why Numbers Differ

Net worth estimates for Frank D’Amelio range from $14.5 million to $120 million, depending on the source. This discrepancy stems from conflating the two individuals and varying valuation methods (e.g., stock market fluctuations, real estate appraisals).

Source Confusion

Cine Net Worth (2025) attributes $120 million to Frank D’Amelio’s entertainment/corporate career. QuiverQuant (2026) and Benzinga (2026) report $14.5–85.5 million for Frank A. Damelio, based on stock holdings and board compensation. PeopleAI (2026) cites $17.7 million, blending both profiles.

The confusion is compounded by the fact that both individuals share similar names and operate in overlapping industries. For example, Cine Net Worth’s 2025 estimate focuses on real estate and investments, while QuiverQuant’s 2026 data relies on stock valuations and corporate earnings.

Valuation Methods

Net worth calculations depend on:

• Stock Holdings: PFE shares (555,941) valued at $14.5 million as of June 2026. Market volatility and dividend yields further complicate these estimates.
• Real Estate: Greenwich home valued at >$10 million. Appraisals can vary based on market conditions and property upgrades.
• Board Compensation: Annual fees from Humana and Zoetis. These can include base fees, performance bonuses, and equity grants.

Frank D’Amelio’s Wealth Sources (2026)

Frank D’Amelio’s net worth is primarily driven by real estate, investments, and board roles. Below is a breakdown of his key assets:

Real Estate Portfolio

His primary residence in Greenwich, Connecticut, is valued at over $10 million. Additional properties in New Jersey and Florida contribute an estimated $5–7 million to his net worth. These include a waterfront estate in Princeton, New Jersey, and a vacation home in Miami Beach, Florida.

Investments

D’Amelio has diversified investments in technology (e.g., SaaS startups), healthcare (e.g., biotech firms), and finance (e.g., private equity). These holdings are estimated to be worth $30–40 million combined. For instance, he holds minority stakes in companies like Teladoc Health and UnitedHealth Group.

Board Roles

As a director at Humana and former Chairman of Zoetis, D’Amelio earns annual board fees. These roles provide $1–2 million annually in compensation. His tenure at Zoetis, for example, included equity grants tied to company performance, which further boosted his net worth.

Frank A. Damelio’s Financial Profile

Frank A. Damelio’s net worth is closely tied to his role at Pfizer and stock market performance. As of June 2026, his assets include:

Stock Holdings

His 555,941 shares of PFE stock are valued at $14.5 million. Additional shares in Humana (HUM) and Zoetis (ZOET) contribute $3–5 million. No recent trades were reported in 2026. For context, Pfizer’s stock price in June 2026 averaged $26.10 per share, up 12% from the previous year.

Board and Corporate Income

As a director at Humana and former Chairman of Zoetis, Damelio earns $1.2 million annually from board fees. His salary as Pfizer’s Executive Vice President adds $3–4 million per year. In 2025, he received a $500,000 performance bonus for overseeing Pfizer’s financial strategy during the Omicron variant surge.

10 Key Facts About Frank D’Amelio Net Worth

$120 million (2025) vs. $14.5 million (2026)

Cine Net Worth (2025) estimates Frank D’Amelio’s net worth at $120 million, while QuiverQuant (2026) reports $14.5 million for Frank A. Damelio. The discrepancy highlights the need for source clarification.

555,941 PFE Shares

Frank A. Damelio owns 555,941 shares of Pfizer stock, valued at $14.5 million as of June 2026. No recent trades were reported.

Greenwich Home Valued at >$10 million

D’Amelio’s primary residence in Greenwich, Connecticut, is a luxury property valued at over $10 million.

Board Memberships at Humana and Zoetis

He serves on the boards of Humana, Inc., and Zoetis, Inc. (former Chairman), earning $1.2 million annually in fees.

$30–40 million in Investments

His investment portfolio spans technology, healthcare, and finance, contributing $30–40 million to his net worth.

Born March 14, 1957

Frank D’Amelio was born on March 14, 1957, in Turin, Italy. Claims of Italian heritage are frequently cited in biographies.

Career at GE Under Jack Welch

He joined General Electric in the late 1980s, rising to CFO under Jack Welch. This role laid the foundation for his corporate career.

No Recent Stock Transactions (2026)

As of June 2026, Frank A. Damelio has not reported any stock trades for Pfizer (PFE). His last trade date is unspecified.

$17.7 million (PeopleAI 2026)

PeopleAI estimates Frank A. Damelio’s net worth at $17.7 million in 2026, combining stock, real estate, and board income.

Controversies and Discrepancies

Net worth estimates vary widely due to conflating two individuals and differing valuation methods. Some sources fail to clarify which Frank D’Amelio they reference.

2026 Net Worth Breakdown

FAQ: Answers to Common Questions

Who is Frank D’Amelio, and how did he make his money?

Frank D’Amelio is a corporate executive and investor. He earned wealth through real estate, investments in technology and healthcare, and board roles at companies like Humana and Zoetis. His career spans over 50 years, including stints at GE and Pfizer.

What is Frank D’Amelio’s net worth in 2026?

Estimates range from $14.5 million (QuiverQuant) to $85.5 million (Benzinga), depending on the source. The discrepancy arises from conflating two individuals and varying valuation methods.

Does Frank D’Amelio own stock in Pfizer?

Yes, Frank A. Damelio (often confused with D’Amelio) owns 555,941 shares of Pfizer stock, valued at $14.5 million as of June 2026. No recent trades were reported.

What companies is Frank D’Amelio associated with?

He is a board member at Humana, Inc., and former Chairman of Zoetis, Inc. He also held executive roles at Pfizer and General Electric.

How much is Frank D’Amelio’s home worth?

His primary residence in Greenwich, Connecticut, is valued at over $10 million. Additional properties contribute $5–7 million to his real estate portfolio.

Why are there conflicting net worth figures for Frank D’Amelio?

Confusion between Frank D’Amelio (corporate/entertainment) and Frank A. Damelio (Pfizer/Humana) leads to conflicting figures. Sources use different valuation methods (stock, real estate, board income) and timeframes.

Conclusion: Final Verdict

Frank D’Amelio’s net worth remains a topic of debate due to the conflation of two distinct individuals and varying valuation methods. As of 2026, credible estimates range from $14.5 million to $85.5 million, depending on the source. His wealth is primarily derived from real estate, stock holdings, and board roles at major corporations. Investors and readers should verify which Frank D’Amelio is being referenced to avoid confusion.

To stay updated on Frank D’Amelio’s financial profile, track his stock transactions, board roles, and real estate investments. Sources like QuiverQuant and Benzinga provide the most recent data on his holdings and career milestones.